Exxel Pharma, INC. S-1
Accession 0001213900-25-089404
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 1:29 PM ET
Size
6.1 MB
Accession
0001213900-25-089404
Documents
- S-1ea0256939-s1_exxel.htmPrimary
REGISTRATION STATEMENT
- EX-2.1ea025693901ex2-1_exxel.htm
SECURITIES EXCHANGE AGREEMENT DATED MARCH 18, 2025, BETWEEN EXXEL PHARMA INC A BRITISH COLUMBIA CORPORATION, EXXEL PHARMA INC, A COLORADO CORPORATION, AND THE SHAREHOLDERS OF EXXEL PHARMA INC A BRITISH COLUMBIA CORPORATION
- EX-3.1ea025693901ex3-1_exxel.htm
ASPIRE BIOSCIENCE, INC. STATEMENT OF CONVERSION AND ARTICLES OF INCORPORATION DATED JUNE 29, 2018
- EX-3.2ea025693901ex3-2_exxel.htm
EXXEL PHARMA INC AMENDED ARTICLES OF INCORPORATION DATED MARCH 26, 2025
- EX-3.3ea025693901ex3-3_exxel.htm
EXXEL PHARMA INC AMENDED AND RESTATED BYLAWS DATED [ ]
- EX-5.1ea025693901ex5-1_exxel.htm
LEGAL OPINION OF FRASCONA, JOINER, GOODMAN & GREENSTEIN, P.C
- EX-10.1ea025693901ex10-1_exxel.htm
EXCLUSIVE LICENSE NO 2022-04-0094 DATED AUGUST 21, 2021 BETWEEN UNIVERSITY OF CALIFORNIA AND EXXEL PHARMA INC
- EX-10.2ea025693901ex10-2_exxel.htm
FIRST AMENDMENT DATED MARCH 7, 2024 TO EXCLUSIVE LICENSE NO 2022-04-0094 BETWEEN UNIVERSITY OF CALIFORNIA AND EXXEL PHARMA INC
- EX-10.3ea025693901ex10-3_exxel.htm
EXCLUSIVE LICENSE NO 2022-04-0096 DATED AUGUST 21, 2021 BETWEEN UNIVERSITY OF CALIFORNIA AND EXXEL PHARMA INC
- EX-10.4ea025693901ex10-4_exxel.htm
FIRST AMENDMENT DATED MARCH 7, 2024 TO EXCLUSIVE LICENSE NO 2022-04-0096 BETWEEN UNIVERSITY OF CALIFORNIA AND EXXEL PHARMA INC
- EX-10.5ea025693901ex10-5_exxel.htm
EMPLOYMENT AGREEMENT OF SOREN MOGELSVANG AS PRESIDENT AND CEO
- EX-10.6ea025693901ex10-6_exxel.htm
CONSULTING AGREEMENT OF RICHARD PAUL, AS CHIEF MEDICAL OFFICER
- EX-10.7ea025693901ex10-7_exxel.htm
CONSULTING AGREEMENT OF DANIELE PIOMELLI AS CHIEF SCIENTIFIC OFFICER
- EX-10.8ea025693901ex10-8_exxel.htm
CONSULTING AGREEMENT OF ROBERT DICKEY AS CHIEF FINANCIAL OFFICER
- EX-10.9ea025693901ex10-9_exxel.htm
SECURITIES PURCHASE AGREEMENT DATED NOVEMBER 19, 2024 BETWEEN EXXEL PHARMA INC. AND INVESTOR
- EX-10.10ea025693901ex10-10_exxel.htm
COMMON STOCK PURCHASE WARRANT AGREEMENT DATED NOVEMBER 19, 2024
- EX-10.11ea025693901ex10-11_exxel.htm
SECOND AMENDMENT DATED AUGUST 8, 2025 TO EXCLUSIVE LICENSE NO 2022-04-0094 BETWEEN UNIVERSITY OF CALIFORNIA AND EXXEL PHARMA INC
- EX-10.12ea025693901ex10-12_exxel.htm
SECOND AMENDMENT DATED AUGUST 28, 2025 TO EXCLUSIVE LICENSE NO 2022-04-0096 BETWEEN UNIVERSITY OF CALIFORNIA AND EXXEL PHARMA INC
- EX-21.1ea025693901ex21-1_exxel.htm
SUBSIDIARIES OF THE REGISTRANT
- EX-23.1ea025693901ex23-1_exxel.htm
CONSENT OF DBBMCKENNON
- EX-99.1ea025693901ex99-1_exxel.htm
CONSENT OF NITIN KAUSHAL AS DIRECTOR NOMINEE
- EX-99.2ea025693901ex99-2_exxel.htm
CONSENT OF ANUJ MEDHOK AS DIRECTOR NOMINEE
- EX-99.3ea025693901ex99-3_exxel.htm
CONSENT OF DEBORAH GERAGHTY AS DIRECTOR NOMINEE
- EX-99.4ea025693901ex99-4_exxel.htm
AUDIT COMMITTEE CHARTER
- EX-99.5ea025693901ex99-5_exxel.htm
COMPENSATION COMMITTEE CHARTER
- EX-99.6ea025693901ex99-6_exxel.htm
CLAWBACK POLICY
- EX-99.7ea025693901ex99-7_exxel.htm
WHISTLEBLOWER POLICY
- EX-FILINGea025693901ex-fee_exxel.htm
FILING FEE TABLE
- GRAPHICimage_001.jpg
GRAPHIC
- GRAPHICimage_002.jpg
GRAPHIC
- GRAPHICimage_003.jpg
GRAPHIC
- GRAPHICimage_004.jpg
GRAPHIC
- GRAPHICimage_005.jpg
GRAPHIC
- GRAPHICimage_006.jpg
GRAPHIC
- GRAPHICimage_007.jpg
GRAPHIC
- GRAPHICimage_008.jpg
GRAPHIC
- GRAPHICimage_009.jpg
GRAPHIC
- GRAPHICimage_009a.jpg
GRAPHIC
- GRAPHICimage_010.jpg
GRAPHIC
- GRAPHICimage_011.jpg
GRAPHIC
- GRAPHICimage_012.jpg
GRAPHIC
- GRAPHICimage_013.jpg
GRAPHIC
- GRAPHICimage_014.jpg
GRAPHIC
- GRAPHICimage_015.jpg
GRAPHIC
- GRAPHICex3-1_001.jpg
GRAPHIC
- GRAPHICex3-1_002.jpg
GRAPHIC
- GRAPHICex3-1_003.jpg
GRAPHIC
- GRAPHICex3-3_001.jpg
GRAPHIC
- GRAPHICex99-1_001.jpg
GRAPHIC
- GRAPHICex99-2_001.jpg
GRAPHIC
- GRAPHICex99-3_001.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLR2.htm
IDEA: XBRL DOCUMENT
- XMLR3.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-089404-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea025693901ex-fee_exxel_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Exxel Pharma, INC.
CIK 0002046638
Related Parties
1- filerCIK 0002046638
Filing Metadata
- Form type
- S-1
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 1:29 PM ET
- Size
- 6.1 MB